Users online: 2066    [ij] [ij] [ij] 
Email id

Research Journal of Pharmacy and Technology
Year : 2019, Volume : 12, Issue : 4
First page : ( 1895) Last page : ( 1900)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2019.00312.3

A Comparative Study of Homology Modeling Algorithms for NPTX2 Structure Prediction

Sowmya H*

Department of Biotechnology, School of Life Sciences, Vels University, Pallavaram, Chennai, Tamil Nadu, India

*Corresponding Author E-mail: sowmya.se@velsuniv.ac.in

Online published on 8 August, 2019.


Alzheimer's Disease (AD) is a very prevalent neurological disorder that results in loss of memory due to the weakening of synapses. Down-regulation of neuronal Pentraxin (NPTX2), a secretory protein is one of the causes for AD. The structure of a protein is very important to predict the protein's function. The experimental structure of NTPX2 is not available yet. Hence in this study, three structures for NPTX2 were generated using Geno3D, Modeller9.20 and Swiss Model. The quality of the protein was validated using PROCHECK and ERRAT. The PROCHECK results for the structures modeled using Geno3D, Modeller, and Swiss Model showed 63%, 87.3% and 88.2% residues in the most favoured regions and 2.5%, 0.0%, 0.00% residues in disallowed regions respectively. The ERRAT results showed an overall quality factor of 90.27, 60.476, 77.54 respectively. The model generated from Swiss Model can be considered as best model because in PROCHECK the model showed high number of residues in the most favoured region and no residues were in the disallowed region. The ERRAT result also showed an overall quality factor greater than 75. Though Geno3D showed a good overall quality factor, it showed about 2.5% residues in the disallowed region. Structure Modeled using Modeller showed good results for Ramachandran plot with no residues in the disallowed region. However, its overall quality factor was only 60.476. These structures predicted can lay a foundation for discovering new drugs for the treatment of AD.



Alzheimer's Disease, Neuronal pentraxin, Geno3D, Modeller, Swiss Model.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
623,772,053 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.